TickerFacts.

Aprea Therapeutics, Inc. (APRE): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$13.57M
Year ended 2024-12-31
2018-12-31: -$15.25M2019-12-31: -$26.74M2020-12-31: -$41.83M2023-12-31: -$12.27M2024-12-31: -$13.57M-$13.57M
2018-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$13.57Mn/m2026-03-16, From 2024-01-01
2023-12-31-$12.27Mn/a2025-03-25, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31-$41.83Mn/m2023-03-30, From 2020-01-01
2019-12-31-$26.74Mn/m2022-03-15, From 2019-01-01
2018-12-31-$15.25Mn/a2021-03-16, From 2018-01-01